Advertisement
Screener

Applied Therapeutics, Inc. Form D

Applied Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-03-13: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2024-02-27; Total offering amount $99,997,998.
  • 2023-05-05: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2023-04-23; Total offering amount $30,000,002.
  • 2018-11-19: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2018-11-05; Total offering amount $56,584,093.
  • 2018-02-20: Federal exemption Rule 506(b); Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2018-02-08; Total offering amount $6,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-03-13Rule 506(b)Equity; OptionToAcquire2024-02-27$99,997,998$99,997,998$031
2023-05-05Rule 506(b)Equity; OptionToAcquire2023-04-23$30,000,002$30,000,002$019
2018-11-19Rule 506(b)Equity; OptionToAcquire2018-11-05$56,584,093$27,158,092$29,426,00137
2018-02-20Rule 506(b)Debt; SecurityToBeAcquired2018-02-08$6,000,000$6,000,000$023